Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease
Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis
The GLP-1 receptor agonists exenatide and liraglutide activate glucose transport by an AMPK-dependent mechanism
They are not intended for human or veterinary use, medical advice, dosing, administration, treatment, or promised outcomes
The drug delivers a mean weight loss of around 15% with consistent tolerability, supporting long-term adherence and prescriber confidence
Brenipatide is the one to watch for sobriety and mental health, not for the scale